Contineum Therapeutics Statistics
NASDAQ: CTNMHealthcareBiotechnologyUSD
12.73+0.08 (+0.63%)
At close: Oct 7, 4:00 PM ET · Delayed 15 min
Contineum Therapeutics by the numbers
Contineum Therapeutics has a market capitalization of $478.9 million based on 32.96M shares outstanding. With trailing EPS of $-1.74, Contineum Therapeutics is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 14.2% below its 50-day average and 7.2% below its 200-day average.
Average daily trading volume is 499.57K shares, or about $6.4 million in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
CTNM valuation vs. peer median
| Metric | CTNM | Peer median | Difference |
|---|---|---|---|
| Market cap | $478.92M | $481.22M | -0% |
| Avg. volume | 499.57K | 1.84M | -73% |
Peer median across 8 companies: ARVN, CAPR, AUTL, ASMB, OVID, ALLO, ACRS, CBIO.
Valuation
- Market cap
- $478.92M
- EPS (TTM)
- $-1.74
- Shares outstanding
- 32.96M
Price and trading
- Previous close
- 12.65
- Open
- 12.42
- Day range
- 12.31 – 13.01
- 52-week range
- 8.60 – 17.79
- 52-week change
- +11.76%
- Beta
- —
- Volume
- 707.73K
- Average volume
- 499.57K
Dividends and events
- Annual dividend
- None
- Next earnings date
- Oct 29, 2026
Additional statistics
- Market Cap
- 478.92M
- Forward Pe
- -6.65
- Eps
- -1.74
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 17.79
- Week52 Low
- 8.60
- Avg Volume
- 499.57K
- Shares Outstanding
- 32.96M
- Ma50
- 14.84
- Ma200
- 13.72
- Earnings Date
- Oct 29, 2026
- Pct From52w High
- -28.42%
- Pct From52w Low
- 48.02%